Psychopharmacology and Psychiatry Updates

In this episode, we explore a striking new Nature study suggesting that lithium deficiency may play a central role in the onset of Alzheimer's disease. Could a simple, overlooked supplement be the key to prevention? Dr. Scott Beach unpacks the science, the promise, and the important caveats.
Faculty: Scott Beach, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here
Earn 0.5 CME: Quick Take Vol. 81
Lithium Orotate: Breakthrough Treatment for Alzheimer's Disease?

In this episode, we explore the nuanced challenge of managing ADHD with stimulant medications during pregnancy. Is stopping the medication always the safer choice — or does untreated ADHD carry risks of its own? Dr. Amanda Koire breaks down the latest evidence to help clinicians make truly informed decisions.
Faculty: Amanda Koire, M.D., Ph.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here
Earn 0.5 CME: Prescribing in Pregnancy: What Every Clinician Should Know
Pregnancy, ADHD, and Stimulants: Making an Informed Choice

In this episode, we examine a surprising repurposing of ondansetron — a common antiemetic — as a potential adjunctive treatment for the notoriously hard-to-treat negative symptoms of schizophrenia. Could a nausea medication help restore motivation and emotional engagement in your patients with residual symptoms despite stable antipsychotic therapy?
Faculty: Oliver Freudenreich, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here
Earn 0.5 CMEs: Quick Take Vol. 81
Is Ondansetron Effective for Negative Symptoms in Schizophrenia?

In this episode, we explore how to manage SSRI treatment in pregnant patients — addressing common fears around fetal malformations, medication switching, and neonatal withdrawal. Can stopping an antidepressant actually do more harm than continuing it?
Faculty: Amanda Koire, M.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here
Earn 0.5 CME: Prescribing in Pregnancy: What Every Clinician Should Know
SSRI Treatment During Pregnancy: A Clinical Case

In this episode, we explore a landmark meta-analysis that challenges decades of fear surrounding IV haloperidol and cardiac risk. Could one of medicine's most persistent myths be costing patients their best treatment option for delirium? Dr. Scott Beach breaks down the evidence.
Faculty: Scott Beach, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here
Earn 0.75 CMEs: Quick Take Vol. 80
IV Haloperidol: Are Cardiac Safety Concerns Overblown?